| Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543960 |
NSE Symbol : CONCORDBIO |
P/E(TTM) : 54.96 |
|
ISIN Demat : INE338H01029 |
Div & Yield% : 0.51 |
EPS(TTM) : 27.18 |
|
Book Value(₹) : 193.06 |
Market Cap(₹Cr) : 15,628.61 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 260.52 | 325.89 | 278.13 | 247.06 | 203.99 | 429.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 260.52 | 325.89 | 278.13 | 247.06 | 203.99 | 429.88 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 13.10 | 15.54 | 10.08 | 13.43 | 13.68 | 9.38 |
| Total Income | 273.61 | 341.43 | 288.22 | 260.49 | 217.67 | 439.27 |
| Total Expenditure | 173.34 | 203.51 | 179.19 | 156.52 | 142.59 | 239.46 |
| PBIDT | 100.27 | 137.92 | 109.03 | 103.97 | 75.07 | 199.81 |
| Interest | 0.02 | 0.06 | 0.06 | 0.06 | 0.06 | 0.10 |
| PBDT | 100.26 | 137.86 | 108.97 | 103.91 | 75.02 | 199.71 |
| Depreciation | 18.05 | 19.49 | 18.67 | 18.39 | 17.78 | 14.62 |
| Tax | 20.37 | 28.65 | 21.57 | 22.00 | 14.08 | 41.82 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.65 | -0.29 | 0.95 | 0.63 | 0.60 | 1.34 |
| Reported Profit After Tax | 61.19 | 90.02 | 67.78 | 62.90 | 42.57 | 141.94 |
| Extra-ordinary Items | 0.00 | 0.00 | -2.46 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 61.19 | 90.02 | 70.24 | 62.90 | 42.57 | 141.94 |
| EPS (Unit Curr.) | 5.85 | 8.60 | 6.48 | 6.01 | 4.07 | 13.57 |
| EPS (Adj) (Unit Curr.) | 5.85 | 8.60 | 6.48 | 6.01 | 4.07 | 13.57 |
| Calculated EPS (Unit Curr.) | 5.85 | 8.61 | 6.48 | 6.01 | 4.07 | 13.57 |
| Calculated EPS (Adj) (Unit Curr.) | 5.85 | 8.61 | 6.48 | 6.01 | 4.07 | 13.57 |
| Calculated EPS (Ann.) (Unit Curr.) | 23.40 | 34.42 | 25.92 | 24.05 | 16.27 | 54.27 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 23.40 | 34.42 | 25.92 | 24.05 | 16.27 | 54.27 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.46 | 10.46 | 10.46 | 10.46 | 10.46 | 10.46 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 38.49 | 42.32 | 39.20 | 42.08 | 36.80 | 46.48 |
| PBDTM(%) | 38.48 | 42.30 | 39.18 | 42.06 | 36.78 | 46.46 |
| PATM(%) | 23.49 | 27.62 | 24.37 | 25.46 | 20.87 | 33.02 |
